ArticleTrials2025

Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants (DIVI): study protocol for a randomized, blinded phase II trial.

Sandra E Juul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.